Prof.Dr. Burhan Turgut

Education and Specialization

• 1988–1992 Istanbul University Cerrahpaşa Faculty of Medicine — Medical Degree
• 1992–1997 Istanbul University Cerrahpaşa Faculty of Medicine, Department of Internal Medicine — Residency
• 2000–2003 Trakya University Faculty of Medicine, Division of Hematology — Hematology Fellowship

Professional Experience

• 2003–2007 Trakya University Faculty of Medicine, Department of Internal Medicine — Faculty Member
• 2007–2010 Trakya University Faculty of Medicine, Department of Internal Medicine — Associate Professor
• 2010–2013 Namık Kemal University Faculty of Medicine, Department of Internal Medicine — Associate Professor
• 2012 Namık Kemal University Faculty of Medicine, Department of Internal Medicine — Professor

International Experience

• 2007 University of Chicago Stem Cell Transplant Center — six-month experience in stem cell (bone marrow) transplantation

Professional Memberships

• 2019–2021 President, Hematology Education and Research Association
• American Society of Hematology
• Turkish Apheresis Society
• Turkish Society of Hematology

Awards

• First Prize, 32nd National Hematology Congress Industry Award, Turkish Society of Hematology, 2006

Selected Academic Publications

• Yeşilaltay Alpay et al. (2024). Myxoma Virus Combination Therapy Enhances Lenalidomide and Bortezomib Treatments for Multiple Myeloma. Pathogens, 13. DOI: 10.3390/pathogens13010072.
• Baysal Mehmet et al. (2023). Immune Thrombotic Thrombocytopenic Purpura in Elderly Patients: The Roles of PLASMIC and French Scores. Turkish Journal of Hematology, 40. DOI: 10.4274/tjh.galenos.2023.2023.0295.
• Broome Catherine M. et al. (2023). Efficacy and Safety of Efgartigimod in Adults with Primary Immune Thrombocytopenia (ADVANCE IV): A Multicentre, Randomised, Placebo-Controlled, Phase 3 Trial. The Lancet. DOI: 10.1016/S0140-6736(23)01460-5.
• Özatlı Düzgün et al. (2023). International Forum: The Turkish Perspective on Apheresis Activity—The Turkish Apheresis Registry Report. Transfusion and Apheresis Science, 62(2). DOI: 10.1016/j.transci.2023.103662.
• Altındağ Avcı Burcu et al. (2023). Patients with Severe Coronavirus Disease 2019 Have High Frequency of Factor V Leiden and Prothrombin Gene Mutations. Blood Coagulation & Fibrinolysis, 34(1), 14–19. DOI: 10.1097/MBC.0000000000001167.

Editorial Experience

• Editor, Special Issue on Lymphomas (TR Dizin), Ortadoğu Reklam Yayımcılık